Volunteers and Doctors who participate in clinical trials help make new therapies a reality. Clinical trials are carefully designed research studies in humans that evaluate the safety and efficacy of an investigational therapy.
ON-GOING CLINICAL TRIALS
Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries
A Study of NTX-001 in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair
Peripheral Nerve Injuries:
NTX-001 is a single use surgical product intended for use in conjunction with standard suture neurorrhaphy of severed nerves in patients between 16 and 80 years of age.
April 13, 2021
Neuraptive Therapeutics Announces FDA Clearance of a Second IND Application for NTX-001 in the Prevention of Postoperative Facial Paralysis and Plans to Initiate a Phase 2 Clinical Study Later This Year
May 14, 2020
Neuraptive Therapeutics Announces FDA has Granted Fast Track Designation to NTX-001 Clinical Development Program for Treatment of Patients with Peripheral Nerve Injuries
April 28, 2020
Neuraptive Therapeutics Announces FDA Clearance of IND Application for NTX-001, a Novel Approach for the Treatment of Patients with Peripheral Nerve Injuries
Clinical Trials 101
What are Clinical Trials?
Clinical trials are research studies that are done to find out if medical treatment can improve people’s health.
Current Clinical Trials
People who take part in clinical trials are volunteers. They are also called “participants”.
Clinical trials are carefully supervised, monitored, and documented. The applicable regulatory authority must grant approval to conduct testing in humans, and clinical trials are overseen by an independent review or ethics committee.
Interested in learning more?
Take a look here for a more in-depth look about the conditions we treat, information on how to participate in a clinical trial, and a listing of our current trials.